Evidence map›Paper›PMID 42649417›Full record

ArticleNature chemical biology2026

Topogenic sequence recognition at TIM complexes revealed by a stendomycin-bound structure.

Yuanyuan Chen, Antony Lurie, Kevin Wu, Kihong Nam, Samantha N Garcia, Nathaniel W M Dempsey, Esben B Svenningsen, Thomas Tørring, Thomas B Poulsen, Alban Ordureau and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuanyuan ChenDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Antony Lurie *Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Kevin Wu *Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Kihong NamCell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Samantha N GarciaDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Nathaniel W M DempseyDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-0537-4197
Esben B SvenningsenDepartment of Chemistry, Aarhus University, Aarhus, Denmark.
Thomas TørringDepartment of Biological and Chemical Engineering, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-5257-2121
Thomas B PoulsenDepartment of Chemistry, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-0763-9996
Alban OrdureauCell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4924-8520
Eunyong ParkDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA. eunyong_park@berkeley.edu.ORCID http://orcid.org/0000-0003-2994-5174

Funding

Molecular Mechanisms of Mitochondrial BiogenesisR01GM147628 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Eunyong Park · 2023 to 2026
$1.3M
Memorial Sloan-Kettering Cancer Center (MSKCC) P30CA008748National Research Foundation of Korea (NRF) 2021R1A6A3A14038416U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM147628
6 · The paper itself

Abstract

In the mitochondrial inner membrane (IM), topogenesis of imported proteins is mediated by TIM23 and TIM22 complexes. TIM23 translocates soluble polypeptides across the IM into the matrix, whereas TIM22 inserts polytopic membrane proteins into the IM. Although functionally distinct, both rely on homologous subunits, Tim17 in TIM23 and Tim22 in TIM22. The underlying mechanisms, however, remain elusive. Here we use structural and functional approaches with yeast Tim17, Tim22 and the TIM23 inhibitor stendomycin. Cryogenic-electron microscopy shows that stendomycin binds to the protein translocation cavity of Tim17, mimicking α-helical topogenic sequences. While Tim22 does not bind stendomycin, a single mutation in its equivalent cavity suffices to enable binding. The cavities of Tim17 and Tim22 are largely interchangeable without disrupting their functions. Lastly, stendomycin triggers a collapse of the membrane potential, likely via its Tim17- or Tim22-dependent translocation across the IM. These findings reveal a mechanistic overlap between protein translocases and insertases.

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.